APT Medical Overview

  • Year Founded
  • 2002

Year Founded

  • Status
  • Public

  • Employees
  • 3,118

Employees

  • Stock Symbol
  • 688617

Stock Symbol

  • Investments
  • 7

  • Share Price
  • $43.18
  • (As of Thursday Closing)

APT Medical General Information

Description

APT Medical Inc is engaged in the research and development, production and sales of electrophysiological and vascular interventional medical devices for cardiovascular and cerebrovascular diseases. Its products are sold in Europe, Eastern Europe, Southeast Asia and other countries and other regions.

Contact Information

Website
www.aptmed.com
Ownership Status
Publicly Held
Financing Status
Formerly VC-backed
Corporate Office
  • Room 601, Building B, Tongfang Information Port
  • No.11 Langshan Road, Nanshan District
  • Shenzhen, Guangdong
  • China
+86 0755
Primary Industry
Therapeutic Devices
Stock Exchange
SHG
Corporate Office
  • Room 601, Building B, Tongfang Information Port
  • No.11 Langshan Road, Nanshan District
  • Shenzhen, Guangdong
  • China
+86 0755

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

APT Medical Stock Performance

As of 19-Nov-2026, APT Medical’s stock price is $43.18. Its current market cap is $6.11B with 142M shares.

(As of Thursday Closing)

Stock Price Previous Close 52 wk Range Market Cap Shares Average Volume EPS
$43.18 $43.20 $25.93 - $44.19 $6.11B 142M 1.56M $1.05

APT Medical Financials Summary

As of 30-Sep-2026, APT Medical has a trailing 12-month revenue of $446M.

In Thousands,
USD
TTM 30-Sep-2026 FY 2025 31-Dec-2025 FY 2024 31-Dec-2024 FY 2023 31-Dec-2023
EV 5,035,496 4,716,990 4,844,104 3,503,918
Revenue 446,053 359,312 287,898 233,249
EBITDA 167,333 143,936 114,745 93,328
Net Income 147,337 114,115 93,813 75,468
Total Assets 599,828 521,940 408,309 362,975
Total Debt 1,789 2,773 1,546 12,676
Public Fundamental Data provided by Morningstar, Inc. disclaimer

APT Medical Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore APT Medical‘s full profile, request access.

Request a free trial

APT Medical Patents

APT Medical Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
US-20260306242-A1 Branch artery reconstruction assist device and s-c branch-first aortic reconstruction system Pending 01-Mar-2023
EP-4674379-A1 Branch artery reconstruction assisting device and s-c branch-first aorta reconstruction system Pending 01-Mar-2023
WO-2024179549-A1 Branch artery reconstruction assisting device and s-c branch-first aorta reconstruction system Inactive 01-Mar-2023
JP-2026507226-A Branch artery reconstruction auxiliary device and sc branch priority aortic reconstruction system Pending 01-Mar-2023
EP-4403124-A1 Ablation catheter Pending 13-Sep-2021 A61B18/1492
To view APT Medical’s complete patent history, request access »

APT Medical Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

APT Medical Investors

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info

This information is available in the PitchBook Platform. To explore APT Medical‘s full profile, request access.

Request a free trial

APT Medical Investments (7)

APT Medical’s most recent deal was a Early Stage VC with Liliang Medical for . The deal was made on 22-Aug-2025.

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
Liliang Medical 22-Aug-2025 Early Stage VC Other Devices and Supplies
Shanghai Hong Tong Industries 15-Jun-2025 Corporate Therapeutic Devices
Hunan EVD 10-May-2023 Later Stage VC Surgical Devices
Ricoton 10-Mar-2023 Later Stage VC Surgical Devices
Innosonics 01-Apr-2022 Corporate Diagnostic Equipment
You’re viewing 5 of 7 investments. Get the full list »

APT Medical ESG

Risk Overview

Risk Rating

Updated November, 17, 2026

31.16 | High Risk

Risk Scale

A lower score indicates better sustainability

Negl

0-10

Low

10-20

Med

20-30

High

30-40

Severe

40+

Exposure

Exposure refers to the extent to which a company is exposed to different material ESG issues

Management

Management is related to actions taken to manage ESG issues

Peers Analysis

Peer performance insights compare the company’s ESG performance to the performance of selected peers to help inform future ESG decisions and drive internal performance improvements.

Global

Covered Companies

of 13,592

Rank

Percentile

Healthcare

Industry

of 590

Rank

Percentile

Medical Devices

Subindustry

of 209

Rank

Percentile

To view APT Medical’s complete esg history, request access »

APT Medical FAQs

  • When was APT Medical founded?

    APT Medical was founded in 2002.

  • Where is APT Medical headquartered?

    APT Medical is headquartered in Shenzhen, China.

  • What is the size of APT Medical?

    APT Medical has 3,118 total employees.

  • What industry is APT Medical in?

    APT Medical’s primary industry is Therapeutic Devices.

  • Is APT Medical a private or public company?

    APT Medical is a Public company.

  • What is APT Medical’s stock symbol?

    The ticker symbol for APT Medical is 688617.

  • What is the current stock price of APT Medical?

    As of 19-Nov-2026 the stock price of APT Medical is $43.18.

  • What is the current market cap of APT Medical?

    The current market capitalization of APT Medical is $6.11B.

  • What is APT Medical’s current revenue?

    The trailing twelve month revenue for APT Medical is $446M.

  • What is APT Medical’s annual earnings per share (EPS)?

    APT Medical’s EPS for 12 months was $1.05.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process